Axiom Therapeutics Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$12.3M
- Investors
-
17
Axiom Therapeutics General Information
Description
Developer of an advanced computational platform designed to treat undruggable diseases. The company offers a model that predicts covalent drug interactions with cancer-causing proteins, helping researchers in cancer treatment and accelerating research and treatment development.
Contact Information
Website
www.axiom-therapeutics.comCorporate Office
- Hale House
- 76-78 Portland Place
- London W1B 1NT
- England, United Kingdom
Corporate Office
- Hale House
- 76-78 Portland Place
- London W1B 1NT
- England, United Kingdom
Axiom Therapeutics Timeline
Axiom Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Seed Round | 25-Aug-2026 | $12.3M | Completed | Generating Revenue | ||
| 5. Accelerator/Incubator | 01-Feb-2026 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Sep-2025 | Completed | Generating Revenue | |||
| 3. Seed Round | 11-Mar-2025 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 14-Aug-2024 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Axiom Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Axiom Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Axiom Therapeutics Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Invest in Healthcare | Family Office | Minority | ||
| Grow London | Accelerator/Incubator | |||
| Atlas SGR | Asset Manager | Minority | ||
| Cambridge Enterprise Ventures | Venture Capital | Minority | ||
| Gaingels | Venture Capital | Minority |
Axiom Therapeutics FAQs
-
When was Axiom Therapeutics founded?
Axiom Therapeutics was founded in 2024.
-
Where is Axiom Therapeutics headquartered?
Axiom Therapeutics is headquartered in London, United Kingdom.
-
What is the size of Axiom Therapeutics?
Axiom Therapeutics has 8 total employees.
-
What industry is Axiom Therapeutics in?
Axiom Therapeutics’s primary industry is Drug Discovery.
-
Is Axiom Therapeutics a private or public company?
Axiom Therapeutics is a Private company.
-
What is Axiom Therapeutics’s current revenue?
The current revenue for Axiom Therapeutics is .
-
How much funding has Axiom Therapeutics raised over time?
Axiom Therapeutics has raised $14.3M.
-
Who are Axiom Therapeutics’s investors?
Invest in Healthcare, Grow London, Atlas SGR, Cambridge Enterprise Ventures, and Gaingels are 5 of 17 investors who have invested in Axiom Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
